Chunming Zhang Selected Research

Chunming Zhang Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 05/2008
8	Squamous Cell Carcinoma of Head and Neck 04/2024 - 01/2012
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2012
3	Carcinogenesis 01/2023 - 11/2019
3	Laryngeal Neoplasms (Laryngeal Cancer) 09/2022 - 12/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 12/2013
2	COVID-19 01/2023 - 12/2020
2	Hypertension (High Blood Pressure) 01/2023 - 12/2020
2	Carcinoma (Carcinomatosis) 09/2022 - 10/2013
2	Lymphatic Metastasis 01/2012 - 05/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024
1	Pathologic Processes 09/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Chondrosarcoma 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Erectile Dysfunction 01/2023
1	Infertility (Sterility) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Obesity 01/2022
1	Polyps 01/2021
1	Infections 12/2020
1	Cytokine Release Syndrome 12/2020
1	Inflammation (Inflammations) 10/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2018
1	Papillary Thyroid Cancer 07/2017
1	Cysts 01/2015
1	Allergic Rhinitis 07/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2012
5	Long Noncoding RNAIBA 10/2023 - 07/2017
5	MicroRNAs (MicroRNA)IBA 09/2023 - 10/2013
2	fascinIBA 04/2024 - 11/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2017
2	Circular RNAIBA 09/2023 - 07/2023
2	CarbonIBA 01/2022 - 01/2015
2	CytokinesIBA 12/2020 - 07/2011
2	Messenger RNA (mRNA)IBA 07/2011 - 05/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2024
1	Activins (Activin)IBA 02/2024
1	Activin Receptors (Activin Receptor)IBA 02/2024
1	6-methyladenineIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	VaccinesIBA 01/2023
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 01/2023
1	GANT 61IBA 01/2023
1	Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2023
1	Death Domain ReceptorsIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	Gly Transfer RNAIBA 01/2023
1	Sincalide FDA Link 01/2022
1	IronIBA 01/2022
1	SulfurIBA 01/2022
1	Explosive Agents (Explosives)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 10/2018
1	Oxygen (Dioxygen)IBA 01/2015
1	Cetuximab (Erbitux)FDA Link 12/2013
1	ezrinIBA 01/2012
1	PaxillinIBA 01/2012
1	Member 3 Group F Nuclear Receptor Subfamily 1IBA 07/2011
1	OvalbuminIBA 07/2011
1	Interleukin-17 (Interleukin 17)IBA 07/2011
1	Interleukin-4 (Interleukin 4)IBA 07/2011
1	Vascular Endothelial Growth Factor CIBA 05/2008
1	N 30IBA 05/2008

Therapy/Procedure

3	Therapeutics 02/2024 - 01/2022
3	Drug Therapy (Chemotherapy) 01/2023 - 12/2013
2	Radiotherapy 01/2023 - 12/2013
2	Chemoradiotherapy 09/2022 - 03/2014
1	Art Therapy 01/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023